Cancer Institute And Hospital, Chinese Academy Of Medical Sciences

This study looks at whether giving extra radiation to the internal mammary lymph nodes can help prevent breast cancer from coming back in high-risk patients. About 2,400 people who had a mastectomy or breast-conserving surgery with positive lymph nodes are taking part. The goal i…

This study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy and radiation can help people with large, hard-to-treat lung cancer. About 50 adults with advanced non-small cell lung cancer that cannot be removed by surgery will receive the combination…

This study tests a combination of the drug glofitamab with chemotherapy (GemOx) in 40 adults with a type of lymphoma that did not respond to initial treatment. The main goal is to see how many patients have their tumors completely disappear for at least 4 weeks. Participants must…

This study tests a three-drug combination (selinexor, thalidomide, and dexamethasone) in 40 adults with a rare blood disorder called Langerhans cell histiocytosis (LCH) that has not responded to or has returned after prior treatment. The goal is to see if the regimen can control …

This study enrolls 4,000 people with urothelial carcinoma (bladder cancer) to test whether artificial intelligence can accurately predict HER2 protein levels using MRI scans and tissue images. The goal is to guide targeted therapy decisions without needing invasive biopsies. Rese…

This study involves 10,000 people with non-small cell lung cancer who received immunotherapy before surgery. Researchers want to find out which follow-up treatments work best to improve survival and prevent cancer from coming back. By analyzing real-world data, they hope to ident…

This study looks at whether changes in tumor DNA found in the blood can help predict how B-cell non-Hodgkin lymphoma will progress. Researchers will collect blood samples from 60 patients before and during treatment to see if DNA levels relate to survival or response. This is an …

This study reviews medical records from 300 people with advanced stomach or gastroesophageal junction cancer. Researchers want to see how different combinations of chemotherapy, radiation, or other treatments given before and after surgery affect how long patients live and whethe…